Last reviewed · How we verify

Domestic Tenofovir Disoproxil Fumarate Tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Phase 1 active Small molecule

Domestic Tenofovir Disoproxil Fumarate Tablets is a Small molecule drug developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. It is currently in Phase 1 development.

At a glance

Generic nameDomestic Tenofovir Disoproxil Fumarate Tablets
SponsorChia Tai Tianqing Pharmaceutical Group Co., Ltd.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Domestic Tenofovir Disoproxil Fumarate Tablets

What is Domestic Tenofovir Disoproxil Fumarate Tablets?

Domestic Tenofovir Disoproxil Fumarate Tablets is a Small molecule drug developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd..

Who makes Domestic Tenofovir Disoproxil Fumarate Tablets?

Domestic Tenofovir Disoproxil Fumarate Tablets is developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (see full Chia Tai Tianqing Pharmaceutical Group Co., Ltd. pipeline at /company/chia-tai-tianqing-pharmaceutical-group-co-ltd).

What development phase is Domestic Tenofovir Disoproxil Fumarate Tablets in?

Domestic Tenofovir Disoproxil Fumarate Tablets is in Phase 1.

Related